WhyFI Matter‪$‬ Kriti

Today we will be unpacking some of Roland Garros’ controversial and chaotic moments and incidents. There's a lot to unpack and a lot to look forwards to in terms of the future of the French Open. 
Support the show

Today on the show, I want to talk about who is going to be the next Roland Garros champion. Oh my gosh there is so much to talk about my friends. I foresee it to be one very exciting and eventful tournament :)


Support the show

Today’s episode is all about the King of Clay, Rafael Nadal himself! 22-time grandslam champion, 2008 Olympic gold in singles, 2016 Olympic Gold in doubles, and 5-time Davis Cup winner! Rafael Nadal is my hero!
Support the show

Today’s episode is a Roland Garros 101 - one for the history buffs and for the people who’ve (let’s just say) have never held a tennis racket. 
Support the show

Hey, guys. I wanted to update you on what’s coming from WhyFI Matter$ over the next few weeks and the summer. So my school, during the month of May, has us all do a May project. As some of you may know, I love tennis. I’ve been playing it for ages, and it’s a huge part of my life.
 
For my project, I am creating a five-episode podcast series all about the upcoming grandslam tennis tournament, Roland Garros.

So instead of the usual topics - economics and finance related- don’t be surprised if you hear me speaking in French or talking about Rafael Nadal. Then during the summer, I will get back to podcasting WhyFi Matter$ content probably every two weeks! I hope this sounds fun and interesting to you, and even if you are not a tennis fan, please consider listening to Drumroll, my new podcast series,
The Greatest Show on Dirt: Roland Garros! 
Support the show

Insulin is expensive. While it costs around 10-13 dollars for manufacturers to produce insulin, big pharma companies are selling it for $250-500 dollars per month. This is because America’s warped pharmaceutical market allows three companies, Eli-Lilly, Sanofi, and Novo Nordisk, to dominate the insulin businesses and set insanely high prices for their drugs. Today I am talking to my friend Siara Patel, a freshman at Boston University and a Type 1 Diabetic. We learn about her journey living with Type 1 Diabetes and the economic challenges she and many other Type 1 and Type 2 diabetics face on a daily basis. After my interview with Siara, we will take a deep dive into why the price of insulin has grown so much in the past 20 years and how this life-saving drug has shifted so far way away from its initial altruistic intent. One of the founders of insulin, Canadian scientist Frederick Benting said, “Insulin belongs to the world.” But we seem to be living in reality far away from this statement. 

Additional resources and information:
https://www.jdrf.org/
https://civicarx.org/
https://diabetes.org/
https://openinsulin.org/
https://www.youtube.com/watch?v=w_RQl1pK11g 


Support the show